Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction

Benzer Materyaller

• Pharmacokinetics, Safety, and Tolerability of Ascending Single Doses of Moxifloxacin, a New 8-Methoxy Quinolone, Administered to Healthy Subjects
  Yazar:: Stass, H., ve diğerleri
  Baskı/Yayın Bilgisi: (1998)
• The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction
  Yazar:: Stass, H, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males
  Yazar:: Stass, H, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Pharmacokinetics of a Once-Daily Oral Dose of Moxifloxacin (Bay 12-8039), a New Enantiomerically Pure 8-Methoxy Quinolone
  Yazar:: Sullivan, John T., ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
  Yazar:: Nakashima, M, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)